| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.1M | — | +85.5% |
| Cost of Revenue | $875K | — | -10.5% |
| Gross Profit | $275K | — | +176.8% |
| R&D Expense | $1.9M | — | +134.5% |
| SG&A Expense | $2.9M | — | +39.0% |
| Operating Income | -$4.5M | — | -39.0% |
| Pre-tax Income | -$7.6M | — | -37.7% |
| Income Tax | $0 | — | -100.0% |
| Net Income | -$7.6M | — | -37.0% |
| EPS (Basic) | -$0.10 | — | +87.5% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $121K | -98.4% | — |
| Inventory | $7.4M | +1.9% | — |
| Current Assets | $9.5M | -54.1% | — |
| Total Assets | $11.2M | -50.2% | — |
| Current Liabilities | $12.7M | -32.3% | — |
| Total Liabilities | $12.7M | -32.5% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$3.8M | — | -69.6% |
| Capital Expenditures | $26K | — | — |
| Investing Cash Flow | -$26K | — | — |
| Financing Cash Flow | -$7.5M | — | -365.4% |
| Free Cash Flow | -$3.8M | — | -70.7% |
| Stockholders' Equity | -$1.4M | -138.2% | +97.0% |